Although neither MRP1 inhibitor alone significantly affected the proliferation of glioblastoma cells at 25 μM, they significantly enhanced the antiproliferative actions of PF-2545920 and MY-5445, particularly in ternary combinations. The gene discussed is ABCC1; the disease is glioblastoma.